- Taro Provides Results for Year Ended March 31, 2024
- Taro to Release Full Year Results on May 20, 2024
- Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote “FOR” Taro Sun Pharma Merger
- Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Key statistics
On Thursday, Taro Pharmaceutical Industries Ltd (TARO:NYQ) closed at 42.75, -6.58% below its 52-week high of 45.76, set on Jan 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 42.72 |
---|---|
High | 42.78 |
Low | 42.68 |
Bid | 42.68 |
Offer | 43.00 |
Previous close | 42.75 |
Average volume | 20.93k |
---|---|
Shares outstanding | 37.58m |
Free float | 8.08m |
P/E (TTM) | 29.83 |
Market cap | 1.61bn USD |
EPS (TTM) | 1.43 USD |
Data delayed at least 15 minutes, as of May 24 2024 00:00 BST.
More ▼